SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095491
Filing Date
2024-08-12
Accepted
2024-08-12 16:30:28
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20240630.htm   iXBRL 10-Q 2226351
2 EX-31.1 bior-ex31_1.htm EX-31.1 16565
3 EX-31.2 bior-ex31_2.htm EX-31.2 17032
4 EX-32.1 bior-ex32_1.htm EX-32.1 14288
  Complete submission text file 0000950170-24-095491.txt   10317781

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20240630.xsd EX-101.SCH 1754991
78 EXTRACTED XBRL INSTANCE DOCUMENT bior-20240630_htm.xml XML 1612515
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 241197198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)